Valuation Lupin Limited

Equities

Market Closed - Bombay S.E. Other stock markets 11:00:56 05/06/2026 BST			5-day change	1st Jan Change
2,268.10 ^INR	+0.86%		-0.19%	+7.39%

06-05	Lupin Gets US FDA Approval for Ranluspec Interchangeable Biosimilar for Eyesight Ailments	MT
06-04	Lupin Limited Receives Approval from U.S. FDA for Ranluspec Ranibizumab Injection	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	463,185	339,061	294,760	737,220	925,229	1,037,011	-	-
Change	-	-26.8%	-13.07%	150.11%	25.5%	12.08%	-	-
Enterprise Value (EV) ¹	476,416	366,521	324,269	751,894	944,572	1,031,180	994,476	960,632
Change	-	-23.07%	-11.53%	131.87%	25.63%	9.17%	-2.86%	-3.4%
P/E ratio	38.2x	-22.2x	68.8x	38.6x	28.3x	19.9x	22.5x	22.1x
PBR	3.36x	2.79x	2.36x	5.16x	5.41x	4.71x	3.95x	3.43x
PEG	-	0x	-1x	0x	0.4x	0.3x	-3.01x	11.41x
Capitalization / Revenue	3.05x	2.07x	1.77x	3.68x	4.07x	3.78x	3.5x	3.32x
EV / Revenue	3.14x	2.23x	1.95x	3.76x	4.16x	3.69x	3.35x	3.08x
EV / EBITDA	18.6x	16.9x	18.8x	19.8x	17.9x	12.6x	13.1x	12.6x
EV / EBIT	28.4x	72.3x	38.6x	28.9x	23x	15.2x	16.4x	16x
EV / FCF	41.6x	-68.2x	81.6x	27.6x	71.7x	19.5x	27.8x	21x
FCF Yield	2.4%	-1.47%	1.23%	3.62%	1.39%	5.12%	3.6%	4.75%
Dividend per Share ²	6.5	4	4	8	12	18	13.06	12.51
Rate of return	0.64%	0.54%	0.62%	0.49%	0.59%	0.78%	0.58%	0.55%
EPS ²	26.72	-33.65	9.41	41.87	71.69	116.4	100.7	102.6
Distribution rate	24.3%	-11.9%	42.5%	19.1%	16.7%	15.5%	13%	12.2%
Net sales ¹	151,630	164,055	166,417	200,108	227,079	279,580	296,474	312,225
EBITDA ¹	25,669	21,656	17,206	38,000	52,775	81,595	75,810	76,425
EBIT ¹	16,795	5,069	8,399	26,032	41,083	67,840	60,498	60,198
Net income ¹	12,165	-15,280	4,301	19,145	32,816	53,328	45,983	46,864
Net Debt ¹	13,231	27,460	29,509	14,674	19,343	-26,138	-42,535	-76,379
Reference price ²	1,020.95	746.05	647.85	1,617.85	2,026.50	2,268.10	2,268.10	2,268.10
Nbr of stocks (in thousands)	453,680	454,475	454,981	455,679	456,565	457,216	-	-
Announcement Date	12/05/21	18/05/22	09/05/23	06/05/24	14/05/25	07/05/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
LUPIN LIMITED	20.85x	3.77x	13.3x	0.59%	10.88B
ELI LILLY AND COMPANY	33.11x	12.04x	24.78x	0.6%	1,009B
JOHNSON & JOHNSON	24.88x	5.74x	15.6x	2.29%	560B
ABBVIE INC.	27.82x	6.77x	13.84x	3.02%	401B
ROCHE HOLDING AG	17.55x	4.34x	10.65x	3.07%	328B
MERCK & CO., INC.	53.89x	5.01x	20.35x	2.77%	298B
ASTRAZENECA PLC	23.42x	4.85x	13.81x	1.8%	288B
NOVARTIS AG	20.62x	5.32x	12.95x	3.06%	272B
NOVO NORDISK A/S	12.56x	4.71x	9.62x	4%	194B
AMGEN INC.	22.73x	6.08x	10.62x	2.89%	189B
Average	25.74x	5.86x	14.55x	2.41%	355.05B
Weighted average by Cap.	28.06x	7.31x	17.00x	2.14%